Current Medicinal Chemistry

Papers
(The H4-Index of Current Medicinal Chemistry is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Preface112
Meet the Editorial Board Member92
Corrigendum to: Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches79
Conformational and Structural Characterization of Carbohydrates and their Interactions Studied by NMR52
Interfering with the Reactive Cysteine Proteome in COVID-1950
Intimal Macrovascular Pericytes: Their Role in Vascular Biology and Atherogenesis49
Challenges of Natural Anticancer and Anti-inflammatory Agents48
Developing Generalizable Scoring Functions for Molecular Docking: Challenges and Perspectives46
Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy46
Integrating Transcriptomic Data and Mendelian RandomizationAnalyses Reveals Potentially Novel Sepsis-related Targets45
An Updated Review Deciphering Apigenin Nanostructures as Promising Therapeutic Efficiency in Human Carcinomas45
Prediction of Prognosis and Immunotherapy Response of Gastric Cancer Based on Glutamine Metabolism-related Genes44
Development in the Inhibition of Dengue Proteases as Drug Targets44
Long Non-coding RNA SNHG16 Facilitates Esophageal Cancer Cell Proliferation and Self-renewal through the microRNA-802/PTCH1 Axis44
Commentary on the Role of Medicinal Cannabis in Healthy Aging and Neuroprotection43
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder42
Neuroinflammatory Human Brain Organoids Enable Comprehensive Drug Screening Studies: Fingolimod and its Analogues in Focus42
Expression of TCEAL2 is a Novel Prognostic Biomarker and Potential Therapeutic Target in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma41
Autophagy-related ncRNAs: Regulatory Roles and Potential Therapeutic Effects in Digestive System Neoplasms41
Identification of Critical Genes Related to Breast Cancer with Brain Metastasis Through Bioinformatics Analysis39
The Pivotal Role of Transient Receptor Potential Channels in Oral Physiology39
Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer38
Role of Ferroptosis in ALD: Focusing on Hepcidin and Besides Hepcidin38
Statins, Allies against Antibiotic Resistance?37
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review35
Exploring the Anticancer Potential of Astragalin in Triple Negative Breast Cancer Cells by Attenuating Glycolytic Pathway through AMPK/mTOR35
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases35
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery33
Drug-Resistant Infections: A Global Challenge for the Future33
Intermittent Fasting and Fasting-mimicking Diet: Promising Strategies in Cancer Management33
Paneth Cells: Recent Updates on Elucidating Therapeutic Implications in Gastroenterological Disease Management33
MEF2C is a Potential Prognostic Biomarker and is Correlated with Immune Infiltrates in Lung Adenocarcinoma33
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile?33
0.101646900177